Details : WNT974 is an oral inhibitor of Porcupine, an acyltransferase that plays a key role in Wnt ligand secretion and activity. Wnt signaling pathways are a group of signal transduction pathways, which begin with proteins that pass signals into a cell through c...
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 27, 2020
Lead Product(s) : WNT974
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 29, 2014
Lead Product(s) : WNT974
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 10, 2011
Reset All
